SAN FRANCISCO (CBS SF) — Action star Chuck Norris’s wife Gena says she has been “to hell and back” over the last five years after being injected with a medical dye during a series of MRI scans.
The couple is taking on medical device manufacturers and San Francisco-based McKesson Corp. in a lawsuit, alleging a chemical used in MRI imaging scans poisoned Gena.READ MORE: 2 San Francisco Residents Arrested On Drug, Gun Charges Following Pursuits In Fresno County
Gadolinium that doctors injected into Gena Norris to improve the clarity of her MRIs have left her weak and tired and with debilitating bouts of pain and a burning sensation, the suit filed in San Francisco Superior Court claimed.
“It’s been a rough five years,” Norris told KPIX 5.
Gena Norris says her body’s reaction to the injection has dramatically changed the quality of her life.
“I went in for a routine MRI, checking for a positive rheumatoid factor and during that time I was actually given three MRIS in the course of eight days,” she said.
Gena Norris said she asked the medical staff if the use of Gadolinium was safe and “they said yes.”
“I started to feel the effects immediately, not connecting anything,” she said. “After the third scan, I was definitely noticing that something was wrong. it started out with this intense burning inside my body that I can’t describe like someone has poured acid on your tissues.”
The pain became more intense until she awoke at 1 a.m. one morning knowing something was very wrong.
“I am a healthy woman,” Gena Norris said. “I’m the lady on the ‘Total Gym’ infomercials next to him. I’ve been fit all my life. So to have anything happen to me like this it was a nightmare.”READ MORE: VIDEO: Woman Dragged By Car In Oakland Chinatown After Having Purse Snatched
Chuck Norris rushed his wife to the hospital early that morning. The couple ended up making five ER over the next few weeks and then there later hospitalizations.
“With each new visit, the burning was spreading,” Gena Norris said of her hospitalizations.
“They poisoned the wrong lady, when they poisoned me,” she added.
Gadolinium is a metal found in so-called contrast agents used in many MRIs. Studies have shown it is retained by organs such as the brain, bones and skin. The American College of Radiology said in a statement last year that gadolinium-based contrast agents have been used for diagnosis and treatment guidance in more than 300 million patients worldwide since the late 1980s and provide “crucial, life-saving medical information.”
The U.S. Food and Drug Administration said in May it found no evidence that retained gadolinium was harmful. A European Union agency reached the same conclusion in July but still recommended suspending some gadolinium contrast agents as a precaution.
The law firm representing the Norris’, Cutter Law, has filed numerous lawsuits in recent weeks on behalf of people who it also says are suffering from gadolinium poisoning.
The Norris’ lawsuit acknowledges no official, publicly stated link between gadolinium and symptoms reported by people who believe the metal has affected their health. But that’s in part because blood and urine testing for gadolinium only became available recently and most doctors were not aware of any disease that was associated with gadolinium other than one that affects people with kidney problems, the lawsuit said.
“One of the problems is this is a very misdiagnosed and underdiagnosed condition,” said Todd Walburg, an attorney for the Norris’.
The lawsuit accuses several manufacturers of gadolinium contrast agents of knowing about their risks, but failing to warn consumers. It seeks more than $10 million in damages, saying the Norris’ have had to spend millions of dollars on treatment for Gena Norris.
Chuck Norris starred in the TV series, “Walker, Texas Ranger.”
TM and © Copyright 2017 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2017 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten. The Associated Press contributed to this report.